Evozyne Revenue and Competitors
Estimated Revenue & Valuation
- Evozyne's estimated annual revenue is currently $10.5M per year.
- Evozyne's estimated revenue per employee is $155,000
- Evozyne's total funding is $135M.
Employee Data
- Evozyne has 68 Employees.
- Evozyne grew their employee count by 3% last year.
Evozyne's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Scientific Officer | Reveal Email/Phone |
3 | Controller | Reveal Email/Phone |
4 | VP, Protein Engineering | Reveal Email/Phone |
5 | Head Mammalian Cell Culture R&D | Reveal Email/Phone |
6 | General Counsel | Reveal Email/Phone |
7 | Senior Director, Talent + HR | Reveal Email/Phone |
8 | Chief Drug Discovery Officer | Reveal Email/Phone |
9 | Director Information Technology | Reveal Email/Phone |
10 | Chief Operating Officer | Reveal Email/Phone |
Evozyne Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2.6M | 17 | -6% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $2.5M | 16 | 0% | N/A | N/A |
#4 | $803.3M | 3239 | 9% | $1.79M | N/A |
#5 | $2.8M | 18 | 64% | N/A | N/A |
#6 | $38.4M | 248 | 18% | N/A | N/A |
#7 | $2M | 13 | -24% | N/A | N/A |
#8 | $1.4M | 9 | -25% | N/A | N/A |
#9 | $1.4M | 9 | 0% | N/A | N/A |
#10 | $2.5M | 16 | 7% | N/A | N/A |
What Is Evozyne?
Evozyne is a data-driven evolution-based molecular engineering platform for building novel, application-specific proteins with advanced functionality.
keywords:N/A
$135M
Total Funding
68
Number of Employees
$10.5M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Evozyne News
2022-04-06 - Takeda/Evozyne Partnership Headlines Hot Week for Gene ...
Evozyne delivered its first protein to Takeda within six months and then went on to design a library of novel proteins with better functionality...
2022-04-06 - Evozyne Announces Multi-Target Research Collaboration and ...
Evozyne combines evolution and deep learning technology to create highly functional novel proteins Natural Machines to solve longstanding...
2022-04-06 - Takeda returns to Evozyne's AI tech, seeking novel proteins ...
Evozyne uses artificial intelligence and machine learning to design novel proteins that can be used in gene therapies. The new agreement with...
Other Companies in Chicago
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $18.7M | 68 | -8% | N/A |
#2 | $8.9M | 68 | 3% | $48.8M |
#3 | $8.9M | 68 | 10% | N/A |
#4 | $7.5M | 68 | 0% | N/A |
#5 | $9.2M | 68 | 750% | N/A |